
Lauren Hill, a 19-year-old college basketball player who inspired millions with her brave battle against brain tumor, died on April 10.
In 2013, Hill was diagnosed after suffering from vertigo and dizziness while playing for her high school team. Doctors said a tumor the size of a lemon was continuing to grow, and there was little they could do.
Advertisement
Hill was a freshman at Ohio's Mount St. Joseph University, where she gained national attention by taking to the court despite her brain tumor diagnosis.
The school convinced the National Collegiate Athletic Association (NCAA) to move up their season opener to give her a chance to play. She made two lay-ups, scoring the first and last baskets of the game.
After the game Hill said, "It's a dream come true to play on a college court, to put my foot down on the floor and hear the roar of the crowd. I just love it so much. I love basketball."
Hill started a non-profit organization "The Cure Starts Now" that has raised over $1.5 million to research a cure for Diffused Intrinsinc Pontine Giloma (DIPG), a rare pediatric brain tumor that affects the brain stem.
Source: Medindia
Advertisement
After the game Hill said, "It's a dream come true to play on a college court, to put my foot down on the floor and hear the roar of the crowd. I just love it so much. I love basketball."
Hill started a non-profit organization "The Cure Starts Now" that has raised over $1.5 million to research a cure for Diffused Intrinsinc Pontine Giloma (DIPG), a rare pediatric brain tumor that affects the brain stem.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News

The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.

New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.

New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.

Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable

A ray of hope for glioma patients as targeted therapy boosts treatment duration.